NFL wide receiver Odell Beckham Jr. is teaming up with Arcutis Biotherapeutics, Inc. to raise awareness about seborrheic dermatitis and roflumilast foam, 0.3% (Zoryve, Arcutis).
Roflumilast foam 0.3%, is indicated for the treatment of seborrheic dermatitis in adult and pediatric patients aged 9 and up. Roflumilast is a once-daily steroid-free selective phosphodiesterase-4 (PDE4) inhibitor.
“My seborrheic dermatitis started to bother me in my 20s when I noticed white flaky skin throughout my beard and at my hairline accompanied by a deep, burning itchy sensation that was extremely uncomfortable,” says Beckham Jr. in a news release.
“After trying to figure out the cause for several years, I finally visited my dermatologist who diagnosed me with seb derm and prescribed ZORYVE foam, which works really well for me. Now I want to help others understand the condition, find a treatment option that works for them, and get a clear win for their skin.”
He adds, “Seb derm is such a common condition but like me, many people may have a hard time trying to figure out what it is and what can be done about it. I want to inspire people not to be embarrassed or discouraged about their condition and instead be empowered to find a dermatologist and work together to find a treatment that works for them.”
“Seborrheic dermatitis is a common condition that I see frequently in my practice, particularly among Black patients,” says Karan Lal, DO, MS, FAAD, double-board certified dermatologist in Scottsdale, AZ, in a news release. “Seb derm is often misunderstood or misdiagnosed, and it can present differently in darker skin tones appearing more purple instead of red, so it is crucial to have a proper diagnosis. The key to managing seborrheic dermatitis effectively is finding the right treatment that works for each individual. ZORYVE is a unique treatment option because it is a steroid-free topical foam that can be used anywhere on the body, including the scalp, face and beard, to help clear skin and reduce itch.”
